Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)

Europace. 2018 May 1;20(5):731-732an. doi: 10.1093/europace/eux373.
No abstract available

Publication types

  • Systematic Review

MeSH terms

  • Anti-Arrhythmia Agents / pharmacology*
  • Arrhythmias, Cardiac* / classification
  • Arrhythmias, Cardiac* / diagnosis
  • Arrhythmias, Cardiac* / drug therapy
  • Clinical Decision-Making / methods*
  • Consensus
  • Drug Monitoring / methods
  • Drug-Related Side Effects and Adverse Reactions / prevention & control
  • Humans
  • Medication Therapy Management / standards*

Substances

  • Anti-Arrhythmia Agents